LigaChem Biosciences Revenue

In the year 2024, LigaChem Biosciences had annual revenue of 125.90B KRW with 268.71% growth. LigaChem Biosciences had revenue of 33.67B in the quarter ending December 31, 2024, with 266.46% growth.

Revenue

125.90B

Revenue Growth

+268.71%

P/S Ratio

31.44

Revenue / Employee

772.38M

Employees

163

Market Cap

3,958.37B

Revenue Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	125.90B	91.75B	268.71%
Dec 31, 2023	34.15B	733.60M	2.20%
Dec 31, 2022	33.41B	1.26B	3.90%
Dec 31, 2021	32.16B	-25.34B	-44.07%
Dec 31, 2019	57.50B	32.26B	127.81%
Dec 31, 2018	Pro	Pro	Pro
Dec 31, 2017	Pro	Pro	Pro
Dec 31, 2016	Pro	Pro	Pro
Dec 31, 2015	Pro	Pro	Pro
Dec 31, 2014	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
Samsung Biologics	4,547.32B
Celltrion	3,557.30B
ALTEOGEN	102.85B
Yuhan	2,067.79B
SK Biopharmaceuticals	547.60B
HLB Co., Ltd.	68.13B
Peptron	3.15B
PharmaResearch	350.12B

Revenue Rankings